|
Volumn 94, Issue 2, 2000, Pages 177-183
|
Equivalence of hydrofluoroalkane (HFA) and chlorofluorocarbons (CFC) formulations of inhaled beclomethasone (multiple letters)
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BECLAZONE CFC FREE;
BECLOMETASONE DIPROPIONATE;
CHLOROFLUOROCARBON;
FLUORINATED HYDROCARBON;
NORFLURANE;
UNCLASSIFIED DRUG;
AREA UNDER THE CURVE;
ASTHMA;
BIOEQUIVALENCE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG FORMULATION;
DRUG POTENCY;
FORCED EXPIRATORY VOLUME;
HUMAN;
LETTER;
METERED DOSE INHALER;
METHODOLOGY;
PRIORITY JOURNAL;
ADMINISTRATION, INHALATION;
AEROSOL PROPELLANTS;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
BECLOMETHASONE;
CHEMISTRY, PHARMACEUTICAL;
CHLOROFLUOROCARBONS;
HUMANS;
HYDROCARBONS, FLUORINATED;
THERAPEUTIC EQUIVALENCY;
|
EID: 0033968843
PISSN: 09546111
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (7)
|
References (0)
|